Desensitization of formyl peptide receptors is abolished in calcium ionophore-primed neutrophils: an association of the ligand-receptor complex to the cytoskeleton is not required for a rapid termination of the NADPH-oxidase response

J Immunol. 1998 Mar 1;160(5):2463-8.

Abstract

Binding of ligands to N-formyl peptide chemoattractant receptors exposed on human neutrophils generates signals in the cells that induce an activation of the superoxide anion producing NADPH-oxidase. Ligand binding is followed by a rapid association of the ligand-receptor complex with the cytoskeleton, a process leading to desensitization of the cells with respect to NADPH-oxidase activation. We show that neutrophils that have experienced an intracellular calcium rise obtained through interaction with the calcium-specific ionophore ionomycin are "primed" with respect to the FMLP-induced production of superoxide anions. Mobilization of FMLP receptors from intracellular pools is one well-known mechanism behind the primed response. Based on our finding that ionomycin-treated neutrophils could not be desensitized, we suggest that the lack of association between the ligand-receptor complex and the cytoskeleton is an additional priming mechanism. Since in vivo-exudated neutrophils, which also had mobilized intracellular organelles, could be desensitized, we suggest that the abolished desensitization in ionomycin-treated neutrophils is not due to an inability of newly recruited receptors to couple to the cytoskeleton. We show that a rapid termination of FMLP-induced superoxide anion production is obtained in both desensitizable and nondesensitizable neutrophils, suggesting that the desensitization phenomenon is of limited importance in the oxidase termination process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cytoplasmic Granules / enzymology
  • Cytoplasmic Granules / metabolism
  • Cytoskeleton / enzymology
  • Cytoskeleton / metabolism*
  • Enzyme Activation / drug effects
  • Humans
  • Ionomycin / pharmacology*
  • Ligands
  • Macromolecular Substances
  • N-Formylmethionine Leucyl-Phenylalanine / blood*
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / blood*
  • Neutrophil Activation / drug effects*
  • Neutrophil Activation / immunology
  • Neutrophils / enzymology
  • Neutrophils / immunology
  • Neutrophils / metabolism*
  • Receptors, Formyl Peptide
  • Receptors, Immunologic / blood
  • Receptors, Immunologic / immunology
  • Receptors, Immunologic / metabolism*
  • Receptors, Peptide / blood
  • Receptors, Peptide / immunology
  • Receptors, Peptide / metabolism*
  • Superoxides / blood

Substances

  • Ligands
  • Macromolecular Substances
  • Receptors, Formyl Peptide
  • Receptors, Immunologic
  • Receptors, Peptide
  • Superoxides
  • Ionomycin
  • N-Formylmethionine Leucyl-Phenylalanine
  • NADPH Oxidases